$1.50+0.15 (+11.11%)
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States.
Solesence, Inc. in the Consumer Defensive sector is trading at $1.50. The stock is currently near its 52-week low of $0.78, remaining 33.0% below its 200-day moving average. Technical signals show overbought RSI of 74 and bullish MACD crossover, explaining why SLSN maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and tita...
Discover why Zacks issues an "Underperform" rating for Solesence, being the first on Wall Street to initiate coverage on the stock. Learn how margin pressure, cash flow weakness, rising leverage and execution challenges are weighing on growth.
Moby summary of Solesence, Inc. Common Stock's Q4 2025 earnings call
Solesence Inc (SLSN) reports a significant turnaround with record annual revenue and improved margins, while outlining ambitious plans for future growth.
Solesence Inc (SLSN) faces revenue and margin pressures but remains optimistic about future growth through strategic reorganization and innovation.
Kevin Carrington: Thank you, operator. Today is a meaningful moment in the history of Solesence, Inc. Common Stock. Today marks Jess Jankowski's final earnings call as a member of the Solesence leadership team.